
| Serial Number | 90372250 |
| Word Mark | ACROPIEL |
| Filing Date | Thursday, December 10, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, May 2, 2023 |
| Registration Number | 7039414 |
| Registration Date | Tuesday, May 2, 2023 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 14, 2023 |
| Goods and Services | On-line retail store services featuring cosmetics, namely, body and beauty care cosmetics, cosmetic preparation for the hair and scalp; Retail store services featuring cosmetics, namely, body and beauty care cosmetics, cosmetic preparation for the hair and scalp; Wholesale store services featuring cosmetics, namely, cosmetic preparations for skin care, anti-aging cosmetic skin care preparations, body and beauty care cosmetics, cosmetic preparations for the hair and scalp, cosmetic soaps, shampoos, dentifrices, lavender oil; On-line wholesale store services featuring cosmetics, namely, cosmetic preparations for skin care, anti-aging cosmetic skin care preparations, body and beauty care cosmetics, cosmetic preparations for the hair and scalp, cosmetic soaps, shampoos, dentifrices, lavender oil |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, February 17, 2021 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | BIOInnotis Co., LTD. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Seoul 08506 KR |
| Party Name | HYUNDAI PHARM CO., LTD. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Chungcheongnam-do 31213 KR |
| Party Name | BIOInnotis Co., LTD. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Seoul 08506 KR |
| Party Name | HYUNDAI PHARM CO., LTD. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Chungcheongnam-do 31213 KR |
| Party Name | BIOInnotis Co., LTD. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Seoul 08506 KR |
| Party Name | HYUNDAI PHARM CO., LTD. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Chungcheongnam-do 31213 KR |
| Event Date | Event Description |
| Tuesday, May 2, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, May 2, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, February 14, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 14, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, January 25, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Sunday, January 8, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, January 5, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, January 5, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, December 31, 2022 | ASSIGNED TO LIE |
| Friday, November 4, 2022 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Monday, August 8, 2022 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Monday, February 7, 2022 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Monday, February 7, 2022 | LETTER OF SUSPENSION E-MAILED |
| Monday, February 7, 2022 | SUSPENSION LETTER WRITTEN |
| Friday, November 19, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, November 18, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, November 18, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, May 29, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Saturday, May 29, 2021 | NON-FINAL ACTION E-MAILED |
| Saturday, May 29, 2021 | NON-FINAL ACTION WRITTEN |
| Friday, May 28, 2021 | ASSIGNED TO EXAMINER |
| Wednesday, February 17, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, December 14, 2020 | NEW APPLICATION ENTERED |